RecruitingPhase 3NCT03150693Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic LeukemiaSponsor: Alliance for Clinical Trials in OncologyAnn Arbor, MI · Battle Creek, MI · Brighton, MI · +452 more sites
RecruitingPhase 2NCT05554393Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)Sponsor: National Cancer Institute (NCI)Brighton, MI · Canton, MI · Chelsea, MI · +172 more sites
RecruitingPhase 2NCT06317649Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)Sponsor: National Cancer Institute (NCI)Brighton, MI · Canton, MI · Chelsea, MI · +222 more sites
RecruitingPhase 2NCT06672146Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)Sponsor: National Cancer Institute (NCI)Brighton, MI · Canton, MI · Chelsea, MI · +132 more sites